%0
Generic
%T
CHARTA: FOLFOX+bevacizumab +/- irinotecan in advanced colorectal cancer (CRC)—Final results of the randomized phase II trial of the AIO (KRK 0209).
%A Schmoll, Hans-Joachim
%A Garlipp, Benjamin
%A Junghanss, Christian
%A Leithaeuser, Malte
%A Vogel, Arndt
%A Schaefers, Michael
%A Kaiser, Ulrich
%A Hoeffkes, Heinz-Gert
%A Florschütz, Axel
%A Rüssel, Jörn
%A Kanzler, Stephan
%A Edelmann, Thomas
%A Forstbauer, Helmut
%A Goehler, Thomas
%A Hannig, Carla
%A Hildebrandt, Bert
%A Steighardt, Jörg
%A Meinert, Fabian Maximilian
%A Cygon, Franziska
%A Stein, Alexander
%I American Society of Clinical Oncology (ASCO)
%@ 0732-183X
%@ 1527-7755
%K Cancer Research
%K Oncology
%D 2017
%C American Society of Clinical Oncology (ASCO)
%U http://slubdd.de/katalog?TN_libero_mab2